INDIANAPOLIS, June 29 (UPI) -- Indiana's Eli Lilly & Co. has notified various European labor groups that it may close as many as three facilities.
The pharmaceutical giant said it may close research facilities in Belgium and Germany and a British factory to cut development costs from $1.1 billion per drug to $800 million per drug, The Wall Street Journal reported Thursday.
Advertisement
About 900 people could be out of work if all the facilities are closed.